Literature DB >> 3440370

In vitro susceptibility of Mycobacterium avium complex to antibacterial agents.

C E Davis1, J L Carpenter, S Trevino, J Koch, A J Ognibene.   

Abstract

In vitro agar dilution susceptibility studies were performed utilizing 20 isolates (24 against rifamycin) of Mycobacterium avium complex against several antimicrobial agents not routinely tested in the mycobacteriology laboratory. Thirteen strains were susceptible to gentamicin at 4 micrograms/ml, 20 to amikacin at 8 micrograms/ml, 18 to streptomycin at 8 micrograms/ml, 20 to kanamycin at 8 micrograms/ml, 20 to trimethoprim/sulfamethoxazole at 2 micrograms/ml, 12 to sulfisoxazole at 10 micrograms/ml, 14 to rifabutin at 1 microgram/ml. No activity was found with penicillin G, cephapirin, moxalactam, vancomycin, clindamycin, erythromycin, trimethoprim, or minocycline. This data suggests a potential use of trimethoprim/sulfamethoxazole, sulfisoxazole, amikacin, gentamicin, and kanamycin in the treatment of infections caused by this group of organisms.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3440370     DOI: 10.1016/0732-8893(87)90165-9

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  9 in total

1.  Bacteriostatic and bactericidal activities of gentamicin alone and in combination with clarithromycin against Mycobacterium avium.

Authors:  L B Heifets; P J Lindholm-Levy; R D Comstock
Journal:  Antimicrob Agents Chemother       Date:  1992-08       Impact factor: 5.191

2.  Amikacin, ciprofloxacin, and imipenem treatment for disseminated Mycobacterium avium complex infection of beige mice.

Authors:  C B Inderlied; P T Kolonoski; M Wu; L S Young
Journal:  Antimicrob Agents Chemother       Date:  1989-02       Impact factor: 5.191

3.  MIC as a quantitative measurement of the susceptibility of Mycobacterium avium strains to seven antituberculosis drugs.

Authors:  L Heifets
Journal:  Antimicrob Agents Chemother       Date:  1988-08       Impact factor: 5.191

4.  Liposome-encapsulated-gentamicin therapy of Mycobacterium avium complex infection in beige mice.

Authors:  S P Klemens; M H Cynamon; C E Swenson; R S Ginsberg
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

5.  A neonate born with Mycobacterium cosmeticum bacteraemia.

Authors:  Wei Li Adeline Koay; Lemuel Aigbivbalu; Janak Patel
Journal:  BMJ Case Rep       Date:  2015-12-23

6.  Comparison of bactericidal activities of streptomycin, amikacin, kanamycin, and capreomycin against Mycobacterium avium and M. tuberculosis.

Authors:  L Heifets; P Lindholm-Levy
Journal:  Antimicrob Agents Chemother       Date:  1989-08       Impact factor: 5.191

7.  Rapid broth macrodilution method for determination of MICs for Mycobacterium avium isolates.

Authors:  S H Siddiqi; L B Heifets; M H Cynamon; N M Hooper; A Laszlo; J P Libonati; P J Lindholm-Levy; N Pearson
Journal:  J Clin Microbiol       Date:  1993-09       Impact factor: 5.948

Review 8.  Clinical pharmacokinetics of rifabutin.

Authors:  M H Skinner; T F Blaschke
Journal:  Clin Pharmacokinet       Date:  1995-02       Impact factor: 6.447

9.  Tuberculosis in Birds: Insights into the Mycobacterium avium Infections.

Authors:  Kuldeep Dhama; Mahesh Mahendran; Ruchi Tiwari; Shambhu Dayal Singh; Deepak Kumar; Shoorvir Singh; Pradeep Mahadev Sawant
Journal:  Vet Med Int       Date:  2011-07-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.